The “viral hypothesis” as an environmental factor that potentially triggers/modulates autoimmune diseases has been studied. Epstein-Barr virus (EBV) stands out as a relevant agent in the pathogenesis of systemic lupus erythematosus (SLE). Therefore, our aim was to evaluate the frequency of EBV molecular detection and its possible clinical and laboratory associations in a prospective cohort of SLE patients.
Methods
An observational prospective study was conducted and SLE patients were evaluated at two timepoints: baseline and after 6 months of follow-up. Clinical and laboratory data were collected from medical records and disease activity (SLEDAI-2K) and accumulated damage (SLICC-DI) scores were calculated. EBV-DNA was detected by real-time polymerase chain reaction (qPCR).
Results
We included 104 patients, 93.2% (n = 97) female with a mean age of 42.6 ± 13.45 years-old. At baseline, 39 (37.5%) patients presented detectable EBV-DNA and this frequency significantly increased at follow-up to 55.4% (p = .02). EBV detection was correlated with laboratory parameters, such as higher serum creatinine (p = .02), urea (p = .04) and ferritin (p = .04) at baseline. In patients with higher viral load (>1000 copies/mL), there was a slight increase in the median SLEDAI-2K (p = .07). Lastly, an age-adjusted logistic regression analysis indicated that immunosuppression at baseline was significantly associated with EBV-DNA positivity (OR = 2.86; 95%CI = 1.08-7.57; p = .03).
Conclusion
The significant increase in EBV positivity during the follow-up of SLE patients may indicate a dynamic variation of viral replication. Moreover, our findings suggest a possible association between EBV, renal manifestations and systemic inflammation in SLE. Finally, we identified that immunosuppression may favor viral replication.
WooJMPParksCGJacobsenS, et al.The role of environmental exposures and gene–environment interactions in the etiology of systemic lupus erythematous. J Intern Med2022; 291(6): 755–778. https://doi.org/10.1111/joim.13448
3.
HarleyJBHarleyITWGuthridgeJM, et al.The curiously suspicious: a role for epstein-barr virus in lupus. Lupus2006; 15(11): 768–777. https://doi.org/10.1177/0961203306070009
4.
KangIQuanTNolascoH, et al.Defective control of latent epstein-barr virus infection in systemic lupus erythematosus. J Immunol2004; 1b72(2): 1287–1294. https://doi.org/10.4049/jimmunol.172.2.1287
5.
DraborgAHJacobsenSWestergaardM, et al.Reduced response to epstein-barr virus antigens by T-cells in systemic lupus erythematosus patients. Lupus Sci Med2014; 1(1): e000015. https://doi.org/10.1136/lupus-2014-000015
6.
McClainMTPooleBDBrunerBF, et al.An altered immune response to epstein‐barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis Rheum2006; 54(1): 360–368. https://doi.org/10.1002/art.21682
7.
RobinsonWHYounisSLoveZZ, et al.Epstein–barr virus as a potentiator of autoimmune diseases. Nat Rev Rheumatol2024; 20(11): 729–740. https://doi.org/10.1038/s41584-024-01167-9
8.
MajerciakVYangWZhengJ, et al.A genome-wide epstein-barr virus polyadenylation map and its antisense RNA to EBNA. J Virol2019; 93(2): e01593. https://doi.org/10.1128/JVI.01593-18
TruszewskaAWirkowskaAGalaK, et al.EBV load is associated with cfDNA fragmentation and renal damage in SLE patients. Lupus2021; 30(8): 1214–1225. https://doi.org/10.1177/09612033211010339
11.
PiroozmandAHaddad KashaniHZamaniB. Correlation between epstein-barr virus infection and disease activity of systemic lupus erythematosus: a cross-sectional study. Asian Pac J Cancer Prev APJCP2017; 18(2): 523–527. https://doi.org/10.22034/APJCP.2017.18.2.523
12.
AringerMCostenbaderKDaikhD, et al.European league against rheumatism/american college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol2019; 71(9): 1400–1412. https://doi.org/10.1002/art.40930
13.
HochbergMC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheumatol1997; 40(9): 1725. https://doi.org/10.1002/art.1780400928
14.
BassARChakravartyEAklEA, et al.American college of rheumatology guideline for vaccinations in patients with rheumatic and musculoskeletal diseases. Arthritis Rheumato2023; 75(3): 449–464. https://doi.org/10.1002/acr.25045
15.
AthanassiouPAthanassiouL. Current treatment approach, emerging therapies and new Horizons in systemic lupus erythematosus. Life2023; 13(7): 1496. https://doi.org/10.3390/life13071496
16.
HahnBHMcMahonMAWilkinsonA, et al.American college of rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res2012; 64(6): 797–808. https://doi.org/10.1002/acr.21664
17.
AlvesPDRohanPHassanR, et al.Lytic and latent genetic diversity of the epstein–barr virus reveals raji-related variants from southeastern Brazil associated with recombination markers. Int J Mol Sci2024; 25: 5002. https://doi.org/10.3390/ijms25095002
18.
KirchmeierDDengYRiebleL, et al.Epstein-barr virus infection induces tissue-resident memory T cells in mucosal lymphoid tissues. JCI Insight2024; 9(20): e173489. https://doi.org/10.1172/jci.insight.173489
19.
GärtnerBCKortmannKSchäferM, et al. No correlation in Epstein-Barr virus reactivation between serological parameters and viral load. J Clin Microbiol. 2000 Jun; 38(6): 2458. https://doi.org/10.1128/JCM.38.6.2458-2458.2000
20.
JensonHB.Virologic Diagnosis, Viral Monitoring, and Treatment of Epstein-Barr Virus Infectious Mononucleosis. Curr Infect Dis Rep. 2004 Jun; 6(3): 200–207. https://doi.org/10.1007/s11908-004-0009-2
21.
ParkYParkBGHaJ, et al.Diagnostic performance and comparative evaluation of the architect, liaison, and platelia epstein-barr virus antibody assays. Ann Lab Med2018; 38(5): 458–465. https://doi.org/10.3343/alm.2018.38.5.458
22.
ByrneABushRJohnsF, et al. Limited Utility of Serology and Heterophile Test in the Early Diagnosis of Epstein–Barr Virus Mononucleosis in a Child after Renal Transplantation. Medicines. 2020; 7: 21. https://doi.org/10.3390/medicines7040021
23.
FrançaSADSVianaJBGDOGóesHCA, et al.Epidemiology of the epstein–barr virus in autoimmune inflammatory rheumatic diseases in northern Brazil. Viruses2022; 14(4): 694.
24.
MiskovicRCirkovicAMiljanovicD, et al.Epstein–barr virus reactivation as a new predictor of achieving remission or lupus low disease activity state in patients with systemic lupus erythematosus with cutaneous involvement. Int J Mol Sci2023; 24(7): 6156. https://doi.org/10.3390/ijms24076156
25.
LinoKAlvesLSTrizzottiN, et al.Evaluation of herpesvirus members on hospital admission in patients with systemic lupus erythematous shows higher frequency of epstein-barr virus and its associated renal dysfunction. Braz J Nephrol2022; 44(4): 490–497. https://doi.org/10.1590/2175-8239-JBN-2021-0184
26.
ChenMTuJHuangM, et al.A retrospective cohort study of epstein-barr virus infection status and systemic lupus erythematosus. Clin Rheumatol2024; 43(5): 1521–1530. https://doi.org/10.1007/s10067-024-06917-4
27.
HanLZhangYWangQ, et al.Epstein–barr virus infection and type I interferon signature in patients with systemic lupus erythematosus. Lupus2018; 27(6): 947–954. https://doi.org/10.1177/0961203317753069
28.
MoppertJDomagalskiKWrotekS, et al.Are selected cytokines and epstein–barr virus DNA load predictors of hepatological complications of epstein–barr virus infection in children?J Clin Med2023; 12(19): 6158. https://doi.org/10.3390/jcm12196158
RenshawAADragoBTorayaN, et al.Respiratory syncytial virus infection is strongly correlated with decreased mean platelet volume. Int J Infect Dis2013; 17(9): e678–e680. https://doi.org/10.1016/j.ijid.2013.01.012
31.
MingBBaiMCaiS, et al.Clinical characteristics of SLE patients infected with epstein-barr virus and potential associated risk factors. Clin Rheumatol2023; 42(1): 101–109. https://doi.org/10.1007/s10067-022-06369-8
32.
StevensSJCPronkIMiddeldorpJM. Toward standardization of epstein-barr virus DNA load monitoring: unfractionated whole blood as preferred clinical specimen. J Clin Microbiol2001; 39(4): 1211–1216. https://doi.org/10.1128/JCM.39.4.1211-1216.2001
33.
KimuraHMoritaMYabutaY, et al.Quantitative analysis of epstein-barr virus load by using a real-time PCR assay. J Clin Microbiol1999; 37(1): 132–136. https://doi.org/10.1128/JCM.37.1.132-136.1999
